Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Extra Horizon is a Belgian digital health and MedTech infrastructure company that provides a certified Medical Backend-as-a-Service platform for building, validating, and scaling cloud-connected medical applications. The company was spun out of Qompium in 2022, building on infrastructure originally developed to support FibriCheck, a CE-marked arrhythmia monitoring application. Its platform is designed to help digital health, medical device, diagnostics, and pharmaceutical teams accelerate product development while addressing cybersecurity, privacy, and regulatory requirements such as ISO 13485, IEC 62304, GDPR, HIPAA, CE, and FDA-oriented workflows. Extra Horizon offers modular backend services, developer tools, and implementation support for use cases including remote patient monitoring, AI/ML-enabled medical devices, imaging, and clinical decision support. The company appears to be a commercial-stage platform business rather than a therapeutics developer, with revenue driven by software infrastructure, compliance-enabling services, and ecosystem partnerships.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Extra Horizon.